{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:05:58Z","timestamp":1782428758431,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Governmental University Hospital Grants"},{"name":"Fredrik & Ingrid Thurings foundation"},{"name":"Foundation V\u00e4xthuset"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ghir.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T12:49:47Z","timestamp":1517489387000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Broad variability in pharmacokinetics of GH following rhGH injections in children"],"prefix":"10.1016","volume":"40","author":[{"given":"Elena","family":"Lundberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4549-8618","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Kristr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Rosberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3167-0667","authenticated-orcid":false,"given":"Kerstin","family":"Albertsson-Wikland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2018.01.004_bb0005","first-page":"148","article-title":"Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children","volume":"104","author":"Kastrup","year":"1983","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ghir.2018.01.004_bb0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1651-2227.1987.tb17138.x","article-title":"The effect of human growth hormone injection frequency on linear growth rate","volume":"337","author":"Albertsson-Wikland","year":"1987","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.ghir.2018.01.004_bb0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1651-2227.1986.tb10163.x","article-title":"Daily subcutaneous administration of human growth hormone in growth hormone deficient children","volume":"75","author":"Albertsson-Wikland","year":"1986","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.ghir.2018.01.004_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2003.10.001","article-title":"Clinical pharmacological aspects of growth hormone administration","volume":"14","author":"Laursen","year":"2004","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2018.01.004_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1015880819328","article-title":"Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration","volume":"7","author":"Supersaxo","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ghir.2018.01.004_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P","article-title":"Lymphatic transport of proteins after subcutaneous administration","volume":"89","author":"Porter","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ghir.2018.01.004_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1520-6017(200002)89:2<168::AID-JPS4>3.0.CO;2-Q","article-title":"Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection","volume":"89","author":"Charman","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ghir.2018.01.004_bb0040","first-page":"6","article-title":"Imitation of normal plasma growth hormone profile by subcutaneous administration of human growth hormone to growth hormone deficient children","volume":"102","author":"Christiansen","year":"1983","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ghir.2018.01.004_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1515\/JPEM.2000.13.3.281","article-title":"Suppression and recovery of GH secretion after GH injection in non-GH deficient short children","volume":"13","author":"Rose","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0050","first-page":"E809","article-title":"Growth hormone secretory rates in children as estimated by deconvolution analysis of 24-h plasma concentration profiles","volume":"257","author":"Albertsson-Wikland","year":"1989","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ghir.2018.01.004_bb0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000363106","article-title":"Growth hormone dose-dependent pubertal growth: a randomized trial in short children with low growth hormone secretion","volume":"82","author":"Albertsson-Wikland","year":"2014","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2018.01.004_bb0060","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1210\/jc.2008-0707","article-title":"Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency","volume":"93","author":"Albertsson-Wikland","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12902-015-0080-8","article-title":"Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain","volume":"15","author":"Lundberg","year":"2015","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.ghir.2018.01.004_bb0070","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1210\/jc.2014-1101","article-title":"IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children","volume":"99","author":"Kristr\u00f6m","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0075","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/clinchem\/43.6.950","article-title":"Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein","volume":"43","author":"Jansson","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ghir.2018.01.004_bb0080","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1651-2227.2002.tb03322.x","article-title":"Swedish population-based longitudinal reference values from birth to 18\u202fyears of age for height, weight and head circumference","volume":"91","author":"Albertsson-Wikland","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2018.01.004_bb0085","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1651-2227.2001.tb01609.x","article-title":"Body mass index reference values (mean and SD) for Swedish children","volume":"90","author":"Karlberg","year":"2001","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2018.01.004_bb0090","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1210\/jcem-73-6-1216","article-title":"Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood","volume":"73","author":"Carlsson","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0095","first-page":"2756","article-title":"Acute and chronic effects of subcutaneous growth hormone (GH) injections on plasma levels of GH binding protein in short children","volume":"80","author":"Bjarnason","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jcem-67-1-36","article-title":"Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients","volume":"67","author":"J\u00f8rgensen","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2125.1999.00892.x","article-title":"The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency","volume":"47","author":"Janssen","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl. 4","key":"10.1016\/j.ghir.2018.01.004_bb0110","first-page":"77","article-title":"Pharmacological aspects of growth hormone replacement therapy: route, frequency and timing of administration","volume":"33","author":"J\u00f8rgensen","year":"1990","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2018.01.004_bb0115","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/BF03343645","article-title":"The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children","volume":"22","author":"Bozzola","year":"1999","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2018.01.004_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1677\/joe.0.1040053","article-title":"Intravenous growth hormone: growth responses to patterned infusions in hypophysectomized rats","volume":"104","author":"Clark","year":"1985","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2018.01.004_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1748-1716.1982.tb06980.x","article-title":"Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats","volume":"114","author":"Jansson","year":"1982","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ghir.2018.01.004_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0169-409X(91)90032-8","article-title":"Chronopharmacology of growth hormone and related peptides","volume":"6","author":"Robinson","year":"1991","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ghir.2018.01.004_bb0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1210\/jcem-67-3-493","article-title":"Analyses of 24-hour growth hormone profiles in children: relation to growth","volume":"67","author":"Albertsson-Wikland","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2265.1988.tb03691.x","article-title":"The relationship between the response to growth hormone therapy and pre-treatment growth hormone secretory status","volume":"28","author":"Hindmarsh","year":"1988","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2018.01.004_bb0145","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1203\/00006450-200010000-00010","article-title":"Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities","volume":"48","author":"Albertsson-Wikland","year":"2000","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2018.01.004_bb0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1515\/JPEM.2001.14.4.355","article-title":"Growth hormone binding protein 2001","volume":"14","author":"Baumann","year":"2001","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0155","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1203\/00006450-199802000-00017","article-title":"Growth hormone-binding protein levels over one year in healthy prepubertal children: intraindividual variation and correlation with height velocity","volume":"43","author":"Gelander","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2018.01.004_bb0160","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/endo-117-4-1309","article-title":"Slow metabolic clearance rate of the 20,000-Dalton variant of human growth hormone: implications for biological activity","volume":"117","author":"Baumann","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2018.01.004_bb0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.0.1200311","article-title":"A dual role of growth hormone as a feminizing and masculinizing factor in the control of sex-specific cytochrome P-450 isozymes in rat liver","volume":"120","author":"Mode","year":"1989","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2018.01.004_bb0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0026-0495(96)90292-9","article-title":"Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: 1. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis","volume":"45","author":"Johansson","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2018.01.004_bb0175","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1210\/jcem-70-6-1616","article-title":"Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices","volume":"70","author":"J\u00f8rgensen","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0180","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/jc.2015-3279","article-title":"A randomized safety and efficacy study of somavaratan (VRS-317), a long-acting rhGH, in pediatric growth hormone deficiency","volume":"101","author":"Moore","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1472-6823-12-26","article-title":"Different thresholds of tissue-specific dose-responses to growth hormone in short prepubertal children","volume":"12","author":"Decker","year":"2012","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.ghir.2018.01.004_bb0190","first-page":"13","article-title":"Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children","volume":"10","author":"Hou","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ghir.2018.01.004_bb0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ghir.2015.07.004","article-title":"Status of long-acting-growth hormone preparations\u20142015","volume":"25","author":"H\u00f6ybye","year":"2015","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2018.01.004_bb0200","first-page":"216","article-title":"Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol","volume":"77","author":"Holl","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0205","first-page":"22","article-title":"Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma","volume":"81","author":"Schaefer","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0210","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1210\/jc.2002-020563","article-title":"Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone","volume":"87","author":"Hansen","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2018.01.004_bb0215","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ghir.2010.07.002","article-title":"Bioequivalence studies for three formulations of a recombinant human growth hormone: challenges and lessons learned","volume":"20","author":"Dao","year":"2010","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2018.01.004_bb0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-0773.1991.tb01252.x","article-title":"Influence of concentration and injection volume on the bioavailability of subcutaneous growth hormone: comparison of administration by ordinary syringe and by injection pen","volume":"68","author":"Blok","year":"1991","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ghir.2018.01.004_bb0225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/106002809302700402","article-title":"Subcutaneous absorption kinetics of two highly concentrated preparations of recombinant human growth hormone","volume":"27","author":"Laursen","year":"1993","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ghir.2018.01.004_bb0230","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2008-1503","article-title":"Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature","volume":"94","author":"Kristr\u00f6m","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637418300145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637418300145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:56Z","timestamp":1761087116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637418300145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":46,"alternative-id":["S1096637418300145"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2018.01.004","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broad variability in pharmacokinetics of GH following rhGH injections in children","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}